Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares, rose in value on Friday, February 14, with price down by -0.24% to the previous day’s close as strong demand from buyers drove the stock to $33.22.
Actively observing the price movement in the last trading, the stock closed the session at $33.30, falling within a range of $32.86 and $34.68. The PE ratio was 2.92 over 12-month period. Referring to stock’s 52-week performance, its high was $62.58, and the low was $24.88. On the whole, AGIO has fluctuated by -0.18% over the past month.
With the market capitalization of Agios Pharmaceuticals Inc currently standing at about $1.89 billion, investors are eagerly awaiting this quarter’s results, scheduled for in March.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 54.5M, with a low estimate of 9.04M and a high estimate of 12.21M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 10.16M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that AGIO’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of AGIO currently trading nearly -1.62% and -10.86% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.19, while the 7-day volatility ratio is showing 4.95% which for the 30-day chart, stands at 4.43%. Furthermore, Agios Pharmaceuticals Inc (AGIO)’s beta value is 0.91, and its average true range (ATR) is 1.66.
A comparison of Agios Pharmaceuticals Inc (AGIO) with its peers suggests the former has fared considerably weaker in the market. AGIO showed an intraday change of -0.24% in last session, and over the past year, it grew by 32.09%%.
Data on historical trading for Agios Pharmaceuticals Inc (NASDAQ:AGIO) indicates that the trading volumes over the past 10 days have averaged 0.68 and over the past 3 months, they’ve averaged 855.70K. According to company’s latest data on outstanding shares, there are 57.16 million shares outstanding.
Nearly 3.36% of Agios Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 102.68% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.03 million shares as on 2025-01-31, resulting in a short ratio of 6.36. According to the data, the short interest in Agios Pharmaceuticals Inc (AGIO) stood at 894.00 of shares outstanding as of 2025-01-31; the number of short shares registered in 2024-12-31 reached 5.53 million. The stock has risen by 1.10% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AGIO stock heading into the next quarter.
